Kmr Blog R&D Spending & Revenues For Cancer Drugs

We read with interest a recent article ("Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval") published in JAMA Internal Medicine by Prasad and Mailankody and wanted to provide our perspective on this...Read more ›